GLW vs PCRX · P/E 101, rev $15.63B vs P/E 174, rev $369.8M
Corning Incorporated (GLW) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Corning Incorporated (GLW) is a electronic components company listed on US.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GLW revenue for 2025-12-31 was $15.63B. Net income was $1.60B. Revenue was up 19.1% from 2024-12-31 to 2025-12-31. GLW currently screens at market cap $44.76B and trailing P/E 100.5.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
GLW currently screens at market cap $44.76B and trailing P/E 100.5. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the GLW and PCRX stock pages for the full models.
Not investment advice.